Cargando…
UNBS5162 induces growth inhibition and apoptosis via inhibiting PI3K/AKT/mTOR pathway in triple negative breast cancer MDA-MB-231 cells
UNBS5162, a naphthalimide derivative, has a strong anticancer effect and low clinical hematological toxicity. UNBS5162 has been shown to have an anticancer effect in numerous cancer types, except triple negative breast cancer (TNBC). To explore this issue, TNBC MDA-MB-231 cells were selected, and th...
Autores principales: | Yue, Xin, Li, Mingzhong, Chen, Dongxiang, Xu, Zhenghua, Sun, Shengrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176139/ https://www.ncbi.nlm.nih.gov/pubmed/30344670 http://dx.doi.org/10.3892/etm.2018.6675 |
Ejemplares similares
-
UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway
por: Ye, Yingyi, et al.
Publicado: (2019) -
UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis
por: Wang, Bing, et al.
Publicado: (2017) -
Tetrandrine-Induced Autophagy in MDA-MB-231 Triple-Negative Breast Cancer Cell through the Inhibition of PI3K/AKT/mTOR Signaling
por: Guo, Yubo, et al.
Publicado: (2019) -
UNBS5162 inhibits the proliferation of human A549 non‐small‐cell lung cancer cells by promoting apoptosis
por: Liu, Cuicui, et al.
Publicado: (2017) -
Ghrelin inhibits cisplatin-induced MDA-MB-231 breast cancer cell apoptosis via PI3K/Akt/mTOR signaling
por: Zhang, Jinyu, et al.
Publicado: (2020)